NAMS vs. PM
NAMS (NewAmsterdam Pharma Company N.V.) and PM (Philip Morris International Inc.) are both stocks. NAMS operates in Biotechnology (Healthcare), while PM operates in Tobacco (Consumer Defensive). Over the past 3 years, NAMS returned 36.19%/yr vs 26.58%/yr for PM. At a 0.02 correlation, their price movements are largely independent.
Performance
NAMS vs. PM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NAMS achieves a -12.14% return, which is significantly lower than PM's 8.93% return.
NAMS
- 1D
- 3.32%
- 1M
- -13.04%
- YTD
- -12.14%
- 6M
- -15.54%
- 1Y
- 71.60%
- 3Y*
- 36.19%
- 5Y*
- —
- 10Y*
- —
PM
- 1D
- -2.93%
- 1M
- -8.37%
- YTD
- 8.93%
- 6M
- 10.40%
- 1Y
- -2.17%
- 3Y*
- 26.58%
- 5Y*
- 17.02%
- 10Y*
- 11.15%
NAMS vs. PM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
NAMS NewAmsterdam Pharma Company N.V. | -12.14% | 36.50% | 130.08% | 2.48% | -0.91% |
PM Philip Morris International Inc. | 8.93% | 37.99% | 34.34% | -1.85% | 5.50% |
Correlation
The correlation between NAMS and PM is -0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.02 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.02 |
Correlation (All Time) Calculated using the full available price history since Nov 23, 2022 | 0.02 |
Fundamentals
NAMS:
-$1.90
PM:
$7.12
NAMS:
118.11
PM:
6.51
NAMS:
$22.57M
PM:
$41.49B
NAMS:
$19.47M
PM:
$27.93B
NAMS:
-$173.45M
PM:
$17.74B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NAMS vs. PM — Risk / Return Rank
NAMS
PM
NAMS vs. PM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for NewAmsterdam Pharma Company N.V. (NAMS) and Philip Morris International Inc. (PM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NAMS | PM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.35 | ||
| Sortino ratioReturn per unit of downside risk | +1.90 | ||
| Omega ratioGain probability vs. loss probability | 1.23 | 1.01 | +0.22 |
| Calmar ratioReturn relative to maximum drawdown | 2.29 | -0.11 | +2.40 |
| Martin ratioReturn relative to average drawdown | 4.53 | -0.20 | +4.73 |
Loading charts...
Drawdowns
NAMS vs. PM - Drawdown Comparison
The maximum NAMS drawdown since its inception was -66.23%, which is greater than PM's maximum drawdown of -42.87%. Use the drawdown chart below to compare losses from any high point for NAMS and PM.
Loading charts...
Drawdown Indicators
| NAMS | PM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -66.23% | -42.87% | -23.36% |
Max Drawdown (1Y)Largest decline over 1 year | -31.41% | -20.64% | -10.77% |
Max Drawdown (3Y)Largest decline over 3 years | -50.98% | -20.64% | -30.34% |
Max Drawdown (5Y)Largest decline over 5 years | — | -22.78% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -42.87% | — |
Current DrawdownCurrent decline from peak | -25.65% | -9.74% | -15.91% |
Average DrawdownAverage peak-to-trough decline | -22.13% | -10.02% | -12.11% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.84% | 10.85% | +4.99% |
Volatility
NAMS vs. PM - Volatility Comparison
NewAmsterdam Pharma Company N.V. (NAMS) has a higher volatility of 11.44% compared to Philip Morris International Inc. (PM) at 8.19%. This indicates that NAMS's price experiences larger fluctuations and is considered to be riskier than PM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NAMS | PM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.44% | 8.19% | +3.25% |
Volatility (6M)Calculated over the trailing 6-month period | 38.00% | 21.28% | +16.72% |
Volatility (1Y)Calculated over the trailing 1-year period | 56.61% | 28.11% | +28.50% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 71.12% | 22.82% | +48.30% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 71.12% | 24.51% | +46.61% |
Dividends
NAMS vs. PM - Dividend Comparison
NAMS has not paid dividends to shareholders, while PM's dividend yield for the trailing twelve months is around 3.33%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NAMS NewAmsterdam Pharma Company N.V. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PM Philip Morris International Inc. | 3.33% | 3.52% | 4.40% | 5.46% | 4.98% | 5.16% | 5.73% | 5.43% | 6.73% | 3.99% | 4.50% | 4.60% |
Financials
NAMS vs. PM - Financials Comparison
This section allows you to compare key financial metrics between NewAmsterdam Pharma Company N.V. and Philip Morris International Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NAMS vs. PM - Profitability Comparison
NAMS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, NewAmsterdam Pharma Company N.V. reported a gross profit of 0.00 and revenue of 3.04M. Therefore, the gross margin over that period was 0.0%.
PM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Philip Morris International Inc. reported a gross profit of 6.91B and revenue of 10.15B. Therefore, the gross margin over that period was 68.1%.
NAMS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, NewAmsterdam Pharma Company N.V. reported an operating income of 0.00 and revenue of 3.04M, resulting in an operating margin of 0.0%.
PM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Philip Morris International Inc. reported an operating income of 3.89B and revenue of 10.15B, resulting in an operating margin of 38.4%.
NAMS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, NewAmsterdam Pharma Company N.V. reported a net income of 0.00 and revenue of 3.04M, resulting in a net margin of 0.0%.
PM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Philip Morris International Inc. reported a net income of 2.44B and revenue of 10.15B, resulting in a net margin of 24.0%.
Frequently Asked Questions
NAMS and PM have a correlation of -0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NAMS has higher volatility (11.44%) compared to PM (8.19%). In terms of maximum drawdown, NAMS dropped -66.23% vs PM's -42.87%.
NAMS currently has the higher Sharpe Ratio (1.27 vs -0.08), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NAMS and PM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer